Lobbying client

INTERCELL INC VALNEVA

Manufacturer and distributor of Japanese Encephalitis Vaccine

Filings
11
Filed by
1
Reported in-house
—
Reported by firms
$291,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2013 to 2015

Filings

11 filings, newest first.
Filing Filed by Amount
2nd Quarter - Termination
2nd Quarter 2015
DALRYMPLE & ASSOCIATES, LLC $14,000 reported
1st Quarter - Report
1st Quarter 2015
DALRYMPLE & ASSOCIATES, LLC $31,000 reported
4th Quarter - Report
4th Quarter 2014
DALRYMPLE & ASSOCIATES, LLC $31,000 reported
3rd Quarter - Report
3rd Quarter 2014
DALRYMPLE & ASSOCIATES, LLC $31,000 reported
2nd Quarter - Report
2nd Quarter 2014
DALRYMPLE & ASSOCIATES, LLC $31,000 reported
1st Quarter - Report
1st Quarter 2014
DALRYMPLE & ASSOCIATES, LLC $31,000 reported
4th Quarter - Report
4th Quarter 2013
DALRYMPLE & ASSOCIATES, LLC $31,000 reported
3rd Quarter - Report (No Activity)
3rd Quarter 2013
DALRYMPLE & ASSOCIATES, LLC $30,000 reported
2nd Quarter - Report
2nd Quarter 2013
DALRYMPLE & ASSOCIATES, LLC $30,000 reported
1st Quarter - Report
1st Quarter 2013
DALRYMPLE & ASSOCIATES, LLC $31,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
DALRYMPLE & ASSOCIATES, LLC 10 $291,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Defense DEF 10
Budget/Appropriations BUD 5

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.